Menu Chiudi

Sclavo Vaccines Association participates in Inno4vac, a European new public-private partnership to innovate vaccine development

The Innovative Medicines Initiative 2 (IMI2) Joint Undertaking mobilised more than € 33 million to support Inno4vac, an innovative public-private partnership to accelerate vaccine R&D timelines. It will focus on the design and application of new and highly advanced predictive models to allow a faster development and manufacturing of novel vaccines.

https://www.lanazione.it/siena/cronaca/accelerare-sviluppo-e-produzione-dei-vaccini-universita-e-sclavo-lavorano-in-tandem-1.6755813